TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24858769

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC) for three menstrual cycles
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC) for more than three cycles
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (women who never used ovulation drugs)
Number of subjects: 78
Study: 21257986

Group type: EXPERIMENTAL
Intervention: Vitamin E (600 IU every other day)
Number of subjects: 38597

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38597
Study: 18990503

Group type: EXPERIMENTAL
Intervention: 80 Gy in 40 fractions within 8 weeks (Group A)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: 62 Gy in 20 fractions within 5 weeks (Group B)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: 56 Gy in 16 fractions (4/wk) of 3.5 Gy (Group C)
Number of subjects: 212
Study: 16850002

Group type: EXPERIMENTAL
Intervention: Enteral diet enriched with eicosapentaenoic acid (EPA), gamma-linolenic acid (GLA), and antioxidants
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control diet (isonitrogenous and isocaloric)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Enteral diet enriched with EPA, GLA, and antioxidants
Number of subjects: 165
Study: 12605431

Group type: EXPERIMENTAL
Intervention: Low power laser therapy + exercise
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Low power laser therapy alone
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Exercise alone
Number of subjects: 75
Study: 10670908

Group type: EXPERIMENTAL
Intervention: manidipine hydrochloride
Number of subjects: 39

Group type: COMPARATOR
Intervention: delapril hydrochloride
Number of subjects: 39
Study: 9356536

Group type: EXPERIMENTAL
Intervention: Iron supplementation (100 mg elemental Fe/d)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 197
Study: 10155247

Group type: EXPERIMENTAL
Intervention: 6Fr guiding catheter
Number of subjects: 160

Group type: COMPARATOR
Intervention: 8Fr guiding catheter
Number of subjects: 160
Study: 2645988

Group type: EXPERIMENTAL
Intervention: Sustained-release morphine sulfate tablet (MS Contin) given every 12 hours
Number of subjects: 17

Group type: COMPARATOR
Intervention: Oral morphine sulfate solution (MSS) given every 4 hours
Number of subjects: 17
Study: 31881407

Group type: EXPERIMENTAL
Intervention: BHC (Better Health Choices) - an 8-session telephone delivered coaching intervention
Number of subjects: 43

Group type: COMPARATOR
Intervention: Treatment as usual (Control Condition)
Number of subjects: 43
Study: 31291811

Group type: EXPERIMENTAL
Intervention: PCNL under local infiltration anesthesia (PCNL-LIA)
Number of subjects: 36

Group type: COMPARATOR
Intervention: PCNL under general anesthesia (PCNL-GA)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: PCNL-LIA
Number of subjects: 36

Group type: COMPARATOR
Intervention: PCNL-GA
Number of subjects: 36
Study: 29156152

Group type: EXPERIMENTAL
Intervention: DHA-rich supplements
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 25398704

Group type: EXPERIMENTAL
Intervention: Early discharge (discharge ≤3 days)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Usual care (routine discharge)
Number of subjects: 215
Study: 23141686

Group type: EXPERIMENTAL
Intervention: Negative-pressure wound therapy (NPWT) applied from the first postoperative day (POD) to the seventh POD.
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (no NPWT treatment).
Number of subjects: 6
Study: 21233260

Group type: EXPERIMENTAL
Intervention: EVADO
Number of subjects: 165
Study: 18928904

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (walking on a treadmill for 60 min)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Rest (control condition)
Number of subjects: 80
Study: 16437736

Group type: EXPERIMENTAL
Intervention: Electrical acupuncture (EA) at acupoint BL15, 2 Hz for 10 minutes
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham electrical acupuncture (control group)
Number of subjects: 10
Study: 12646779

Group type: EXPERIMENTAL
Intervention: Elongated cannula placed in the aorta descendens
Number of subjects: 60

Group type: COMPARATOR
Intervention: Short aorta ascendens cannula
Number of subjects: 60
Study: 11120549

Group type: EXPERIMENTAL
Intervention: Calcium acetate (5.6 g/day)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Calcium carbonate (6.2 g/day)
Number of subjects: 52
Study: 9343128

Group type: EXPERIMENTAL
Intervention: Trunk centred coordinates
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Single word reading task with stimuli presented to the right of the body's midline
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 6
Study: 8421037

Group type: EXPERIMENTAL
Intervention: Bone scintigraphy management
Number of subjects: 160

Group type: COMPARATOR
Intervention: Positive radiographs treatment (cast for 12 weeks)
Number of subjects: 160
Study: 3891284

Group type: EXPERIMENTAL
Intervention: Ceruletide 0.5 micrograms/kg
Number of subjects: 82

Group type: COMPARATOR
Intervention: Pentazocine 0.5 mg/kg
Number of subjects: 82
Study: 30656404

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1.0 µg/kg/hr for 1 hour, followed by 0.2 µg/kg/hr)
Number of subjects: 47

Group type: COMPARATOR
Intervention: 0.9% saline (control group)
Number of subjects: 47
Study: 29973211

Group type: EXPERIMENTAL
Intervention: Group-based commercial weight loss programme (CP)
Number of subjects: 467

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 467

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 467
Study: 27632856

Group type: EXPERIMENTAL
Intervention: Whole-Body-Vibration (WBV) training combined with trunk-muscle training for 8 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-WBV group performing the same muscle-training program without WBV for 8 weeks
Number of subjects: 20
Study: 25407009

Group type: EXPERIMENTAL
Intervention: Group schema therapy (GST)
Number of subjects: 448

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 448
Study: 25276703

Group type: EXPERIMENTAL
Intervention: Inhaled lavender scent 30 minutes before IUD insertion
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo inhalation 30 minutes before IUD insertion
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Inhaled lavender scent
Number of subjects: 106
Study: 20878048

Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (n = 11)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (n = 14)
Number of subjects: 25
Study: 18628435

Group type: EXPERIMENTAL
Intervention: F&V diet (high in selected citrus fruit, crucifers, and soy)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Basal diet (devoid of fruits, vegetables, and soy)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: F&V diet
Number of subjects: 63
Study: 16104966

Group type: EXPERIMENTAL
Intervention: CIC (scaled with Gracey curettes)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CIUS (scaled with ultrasonic device)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CDC (calculus deattachment with Gracey curettes and brushing with saline solution)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CDUS (calculus deattachment with ultrasonic device and brushing with saline solution)
Number of subjects: 40
Study: 11818641

Group type: EXPERIMENTAL
Intervention: abciximab plus low-dose heparin
Number of subjects: 107

Group type: COMPARATOR
Intervention: standard-dose heparin
Number of subjects: 107
Study: 10362368

Group type: EXPERIMENTAL
Intervention: Warfarin (target INR 2.0 to 2.5) and Aspirin (150 mg) daily
Number of subjects: 43

Group type: COMPARATOR
Intervention: Aspirin (150 mg) alone
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Higher baseline culprit artery CTFC
Number of subjects: 43
Study: 7572757

Group type: EXPERIMENTAL
Intervention: Epidermal growth factor (EGF) mouthwash
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2344298

Group type: EXPERIMENTAL
Intervention: Dietary cholesterol (700 mg/day of egg yolk cholesterol)
Number of subjects: 56
Study: 7149451

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) consisting of breathing through an inspiratory resistance (IR) for 15 min twice daily for 4 weeks
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control period (4 weeks without IMT)
Number of subjects: 11
Study: 31990759

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 30943832

Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 29892

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 29892

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 29892

Group type: COMPARATOR
Intervention: Chlorthalidone
Number of subjects: 29892
Study: 28408020

Group type: EXPERIMENTAL
Intervention: IABP‐SHOCK II risk score (derived from six independent predictors)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: IABP‐SHOCK II risk score (external validation in CardShock trial)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: IABP‐SHOCK II risk score (Kaplan-Meier analysis)
Number of subjects: 137
Study: 26238707

Group type: EXPERIMENTAL
Intervention: Alisporivir 600 mg once daily with peginterferon-α2a and ribavirin (PR)
Number of subjects: 1081

Group type: EXPERIMENTAL
Intervention: Alisporivir 400 mg twice daily with peginterferon-α2a and ribavirin (PR)
Number of subjects: 1081

Group type: COMPARATOR
Intervention: Peginterferon-α2a and ribavirin (PR) alone
Number of subjects: 1081

Group type: EXPERIMENTAL
Intervention: Alisporivir/PR
Number of subjects: 1081
Study: 24332123

Group type: EXPERIMENTAL
Intervention: DC-5ARI (discontinue 5α-reductase inhibitor)
Number of subjects: 230

Group type: COMPARATOR
Intervention: DC-α-blocker (discontinue α-blocker)
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: DC-5ARI
Number of subjects: 230

Group type: COMPARATOR
Intervention: DC-α-blocker
Number of subjects: 230
Study: 22989086

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (16 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nonexercise control
Number of subjects: 30
Study: 19028052

Group type: EXPERIMENTAL
Intervention: Cold blood (4 degrees C blood)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Cold crystalloid (4 degrees C lactated Ringer's solution)
Number of subjects: 172
Study: 17296194

Group type: EXPERIMENTAL
Intervention: Hysterosalpingography (HSG) followed by laparoscopy
Number of subjects: 178

Group type: COMPARATOR
Intervention: Immediate laparoscopy
Number of subjects: 178
Study: 15482084

Group type: EXPERIMENTAL
Intervention: Imagery-induced craving (imagined a scene describing smoking urges)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Rest (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Repeated measurement of TCQ
Number of subjects: 40
Study: 11561388

Group type: EXPERIMENTAL
Intervention: Motivational feedback
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Task feedback
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Motivation and task feedback
Number of subjects: 103

Group type: COMPARATOR
Intervention: No feedback
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: All feedback types
Number of subjects: 103
Study: 9626838

Group type: EXPERIMENTAL
Intervention: Endothelin-1 infusion
Number of subjects: 10
Study: 7933325

Group type: EXPERIMENTAL
Intervention: Trivalent split‐antigen vaccine containing A/Beijing/352/89 (H3N2) and B/Bangkok/163/90 (B/Panama/45/90‐like strain)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control group (unvaccinated)
Number of subjects: 137
Study: 3261766

Group type: EXPERIMENTAL
Intervention: Injection of phenol (5%) in arachis oil with bulk laxative (Group 1)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Bulk laxative alone (Group 2)
Number of subjects: 43
Study: 30231640

Group type: EXPERIMENTAL
Intervention: Pro-evolution opinion paired with a male celebrity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-evolution opinion paired with a male celebrity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Neutral opinion paired with a male celebrity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pro-evolution opinion paired with a female celebrity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pro-evolution opinion paired with a male expert
Number of subjects: 0
Study: 26857949

Group type: EXPERIMENTAL
Intervention: Nebulized albuterol (10 mg over 1 hour)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (nebulized saline)
Number of subjects: 28
Study: 25659589

Group type: EXPERIMENTAL
Intervention: Community-based peer support intervention
Number of subjects: 192
Study: 23761482

Group type: EXPERIMENTAL
Intervention: S (100% soybean oil)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: MS (50% medium‐chain triglycerides and 50% soybean oil)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: MSF (50% medium‐chain triglycerides, 40% soybean oil, and 10% fish oil)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: OS (80% olive oil and 20% soybean oil)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: MOSF (30% medium‐chain triglycerides, 25% olive oil, 30% soybean oil, and 15% fish oil)
Number of subjects: 144
Study: 21223712

Group type: EXPERIMENTAL
Intervention: CTOP
Number of subjects: 196

Group type: COMPARATOR
Intervention: CHOP
Number of subjects: 196
Study: 18371487

Group type: EXPERIMENTAL
Intervention: Darbepoetin alpha (1.5 microg/kg every 20 days for 3 months) plus oral iron
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo plus oral iron
Number of subjects: 32
Study: 16817918

Group type: EXPERIMENTAL
Intervention: Hyoscine butylbromide 10 mg t.d.s.
Number of subjects: 1637

Group type: EXPERIMENTAL
Intervention: Paracetamol 500 mg t.d.s.
Number of subjects: 1637

Group type: EXPERIMENTAL
Intervention: Fixed combination of hyoscine and paracetamol
Number of subjects: 1637

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1637
Study: 15013050

Group type: EXPERIMENTAL
Intervention: VPA 125 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VPA 250 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VPA 375 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VPA 500 mg per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VPA (all doses)
Number of subjects: 0
Study: 10962418

Group type: EXPERIMENTAL
Intervention: Aprotinin (500,000 KIU)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 9066324

Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil diluted with dextrose (10 micrograms)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intrathecal sufentanil diluted with normal saline (10 micrograms)
Number of subjects: 40
Study: 8092794

Group type: EXPERIMENTAL
Intervention: Intraoperative ultrasonography
Number of subjects: 0

Group type: COMPARATOR
Intervention: Preoperative ultrasonography
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intraoperative palpation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intraoperative exploration (palpation or ultrasound, or both)
Number of subjects: 0
Study: 3012808

Group type: EXPERIMENTAL
Intervention: Sulbactam (1 gram) and ampicillin (2 grams) every six hours
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clindamycin (600 mg) every six hours and tobramycin (1.5 mg/kg) every eight hours
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sulbactam and ampicillin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Clindamycin and tobramycin
Number of subjects: 60
Study: 31871045

Group type: EXPERIMENTAL
Intervention: Hydroxyurea (HU)
Number of subjects: 43
Study: 29059417

Group type: EXPERIMENTAL
Intervention: Let's Talk About Smoking (interactive web-based motivational tool)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Standard education (computerized standard education from the National Cancer Institute)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Naturalistic comparison condition (minimal tobacco assessment at baseline, no intervention)
Number of subjects: 81
Study: 27922760

Group type: EXPERIMENTAL
Intervention: NerveCheck (quantitative sensory testing device)
Number of subjects: 144
Study: 23568039

Group type: EXPERIMENTAL
Intervention: Nasal surgery
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (43 healthy volunteers)
Number of subjects: 38
Study: 23328235

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA) with computed tomographic (CT) guidance in Group A (19 patients)
Number of subjects: 32

Group type: COMPARATOR
Intervention: No additional treatment for metastatic lymph nodes in Group B (13 patients)
Number of subjects: 32
Study: 20801120

Group type: EXPERIMENTAL
Intervention: 30 mg of lansoprazole twice daily
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study: 18727689

Group type: EXPERIMENTAL
Intervention: Antidepressants (AD) + mood stabilizer (MS)
Number of subjects: 350
Study: 15537676

Group type: EXPERIMENTAL
Intervention: Ketamine (two doses of intravenous ketamine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 12682003

Group type: EXPERIMENTAL
Intervention: Intracoronary abciximab (20 mg bolus)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Intravenous abciximab (20 mg bolus)
Number of subjects: 403
Study: 10230256

Group type: EXPERIMENTAL
Intervention: Peripheral leukocyte count greater than 13,000/mm3
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Pleural or pulmonary alterations observed on chest X‐ray
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Peripheral leukocyte count greater than 13,000/mm3 and/or pleural or pulmonary alterations on chest X‐ray
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Ranson criteria greater than or equal to three
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Alterations on chest X‐rays
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Alteration of at least one of the abnormal findings on the chest X‐ray and a peripheral leukocyte count greater than 13,000/mm3
Number of subjects: 181
Study: 8728459

Group type: EXPERIMENTAL
Intervention: High-velocity, low-amplitude cervical manipulation twice a week for 3 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: Low-level laser in the upper cervical region and deep friction massage in the lower cervical/upper thoracic region, twice a week for 3 weeks
Number of subjects: 39
Study: 1925506

Group type: EXPERIMENTAL
Intervention: Intravenous insulin infusion
Number of subjects: 69

Group type: COMPARATOR
Intervention: Routine control
Number of subjects: 69
Study: 6345374

Group type: EXPERIMENTAL
Intervention: 20 mg nifedipine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 40 mg nifedipine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 60 mg nifedipine
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: All doses of nifedipine (20 mg, 40 mg, 60 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nifedipine (all doses)
Number of subjects: 8
Study: 31556824

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MoI) intervention with initial counseling call and up to 2 monthly follow-up calls by pharmacy students trained in MoI.
Number of subjects: 456

Group type: COMPARATOR
Intervention: Control group (no MoI intervention).
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MoI) intervention.
Number of subjects: 456
Study: 29336388

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 108
Study: 27574437

Group type: EXPERIMENTAL
Intervention: Vildagliptin 50 mg once daily (qd) or twice daily (bid)
Number of subjects: 2108
Study: 24585720

Group type: EXPERIMENTAL
Intervention: FOLFOX/cetuximab (arm A)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: FOLFIRI/cetuximab (arm B)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: R0 resection (n = 36)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: No R0 resection
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: R0 resection
Number of subjects: 111
Study: 22170083

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy 5 × 5 Gy, operated on 7-10 days after irradiation
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy 5 × 5 Gy, operated on after 4-5 weeks
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy 5 × 5 Gy, patients with downstaging
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy 5 × 5 Gy, longer time interval between radiotherapy and surgery
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy 5 × 5 Gy
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy 5 × 5 Gy, longer time interval
Number of subjects: 154
Study: 20645219

Group type: EXPERIMENTAL
Intervention: Short-term dynamic psychotherapy (STDP)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Cognitive therapy (CT)
Number of subjects: 49
Study: 17923721

Group type: EXPERIMENTAL
Intervention: Intervention group (obesity prevention programme)
Number of subjects: 434

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 434
Study: 15303141

Group type: EXPERIMENTAL
Intervention: MBT appliance with en masse retraction
Number of subjects: 37

Group type: COMPARATOR
Intervention: MBT appliance with two-step retraction
Number of subjects: 37
Study: 11952200

Group type: EXPERIMENTAL
Intervention: Behavioral Couples Therapy (BCT)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Individual-Based Treatment (IBT)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Couples-Based Psychoeducational Attention Control Treatment (PACT)
Number of subjects: 135
Study: 9608988

Group type: EXPERIMENTAL
Intervention: 50% nitrous oxide in oxygen
Number of subjects: 32

Group type: COMPARATOR
Intervention: Oxygen
Number of subjects: 32
Study: 7618938

Group type: EXPERIMENTAL
Intervention: Length measurement at birth
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Length measurement at 6 weeks
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Length measurement at 8 months
Number of subjects: 38
Study: 2696150

Group type: EXPERIMENTAL
Intervention: Amalgam fillings
Number of subjects: 154

Group type: COMPARATOR
Intervention: Castings
Number of subjects: 154